Yesterday Mylan, and Hospira and Celltrion (jointly) filed amicus briefs in support of Apotex’s appeal to the Federal Circuit in Amgen v. Apotex. They joined the Biosimilars Council, which filed its amicus brief Wednesday. Further analysis to come.
Related Content
- Big Molecule WatchApril 15, 2025
FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs
- Big Molecule WatchApril 11, 2025
FDA Approves Biocon Biologics’ Bevacizumab Biosimilar
- Big Molecule WatchApril 9, 2025
Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar
- Big Molecule WatchApril 7, 2025
GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit
- Big Molecule WatchApril 7, 2025
EMA Seeks Input on a “Tailored Clinical Approach” in Biosimilar Development
- Big Molecule WatchApril 7, 2025
Accord Receives Positive EMA Opinion for Two Denosumab Biosimilars
- Big Molecule WatchApril 3, 2025
Global Biosimilar Updates – Spring 2025
- Big Molecule WatchApril 3, 2025
Commercialization of Ustekinumab and Golimumab Biosimilars
- Awards and RankingsSeptember 9, 2024
Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards
- Awards and RankingsSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Awards and RankingsOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Awards and RankingsOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson
- EventsDecember 5, 2020
China's Patent Linkage System: Can Strategies that Work in the U.S. System Be Applied to China?
- Awards and RankingsOctober 5, 2020
Goodwin Named An LMG Life Sciences Life Cycle Firm For The Ninth Consecutive Year